Abstract:This paper describes the characterization of solid lipid nanodispersions (SLN) prepared with a 1:1 mixture of theobroma oil and goat fat as the main lipid matrix and Phospholipon 90G (P90G) as a stabilizer heterolipid, using polysorbate 80 as the mobile surfactant, with a view to applying the SLN in drug delivery. The 1:1 lipid mixture and P90G constituting the lipid matrix was first homogeneously prepared by fusion. Thereafter, the SLN were formulated with a gradient of polysorbate 80 and constant lipid matrix concentration by melt-high pressure homogenisation. The SLN were characterized by time-resolved particle size analysis, zeta potential and osmotic pressure measurements, differential scanning calorimetry (DSC) and wide angle X-ray diffraction (WAXD). Transmission electron microscopy (TEM) and isothermal heat conduction microcalorimetry (IMC) which monitors the in situ crystallization were also carried out on the SLN containing P90G and 1.0 % w/w of polysorbate 80. The results obtained in these studies were compared with SLN prepared with theobroma oil with and without phospholipid. Particle size analysis of SLN indicated reduction in size with increase in concentration of mobile surfactant and was in the lower nanometer range after 3 months except SLN prepared without P90G or polysorbate 80. The lipid nanoparticles had negative potentials after 3 months. WAXD and DSC studies revealed low crystalline SLN after 3 months of storage except in WAXD of SLN formulated with 1.0 % w/w polysorbate 80. TEM micrograph of the SLN containing 1.0 % w/w polysorbate 80 revealed discrete particles whose sizes were in consonance with the static light scattering measurement. In situ crystallization studies in IMC revealed delayed crystallization of the SLN with 1.0 % w/w polysorbate 80. Results indicate lipid mixtures produced SLN with lower crystallinity and higher particle sizes compared with SLN prepared with theobroma oil alone with or without P90G, and would lead to higher drug incorporation efficiency when used in formulation of actives. Mixtures of theobroma oil and goat fat would be suitable for the preparation of nanostructured lipid carriers. SLN of theobroma oil containing phospholipid could prove to be a good ocular or parenteral drug delivery system considering the low particle size, particle size stability and in vivo tolerability of the component lipids. SLN prepared with lipid admixture, which had higher increase in d(90%) on storage are suitable for preparation of topical and transdermal products.

Preparation of Prednisolone Acetate Solid Lipid Nanoparticles

Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As A Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): A Physico-Chemical Study

Single-component Solid Lipid Nanocarriers Prepared with Ultra-Long Chain Amphiphilic Lipids.

Solid Lipid Nanoparticles Prepared by Solvent Diffusion Method in a Nanoreactor System

Preparation and Pharmaceutical Property of Prednisolone Acetate Ethosomes

Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles

Solid Self-Nanoemulsifying Cyclosporin A Pellets Prepared by Fluid-Bed Coating: Preparation, Characterization and in Vitro Redispersibility

A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release

Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization

Solid Self-Nanoemulsifying Cyclosporine A Pellets Prepared by Fluid-Bed Coating: Stability and Bioavailability Study

Preparation of Osthol Loaded Solid Lipid Nanoparticles

Nanoparticle-Laden Contact Lens for Controlled Ocular Delivery of Prednisolone: Formulation Optimization Using Statistical Experimental Design

Supercritical Assisted Atomization for Preparation of Solid Lipid Nanoparticles

Preparation and Characterization of Prednisolone Acetate Microemulsion for Ophthalmic Use

[Preparation of Solid Lipid Nanoparticles by Solvent Diffusion Method].

Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach

Controllable Preparation of 10 Nm Solid Lipid Nanoparticles Based on Phase Behaviors of Drug-Loading Hot Microemulsions

Solid lipid nanoparticles as an effective sodium aescinate delivery system: formulation and anti-inflammatory activity

The Use of Data Mining for Obtaining Deeper Insights into the Fabrication of Prednisolone-Loaded Chitosan Nanoparticles

Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

Solid Lipid Nanoparticles: A Review of their Biomedical Applications and Preparation